Clinical Trials

Latest Clinical Trials

Optimal IVUS Guidance for Stent Placement: A Clear Winner?

The results of the ULTIMATE trial, presented at the TCT conference 2018,…

How Accurate is the Fractional Flow Reserve Derived From Routine Coronary Angiography?

The FAST-FFR study conducted by Fearon and his colleagues, and presented at…

Landmark COAPT trial Demonstrates the Benefit of Transcatheter Mitral-Valve Repair Using MitraClip in Patients with Heart Failure

The spectacular results of the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous…

Polymer-Free Amphilimus-Eluting stents: A Novel Elution Technology

Polymer-free amphilimus-eluting stentsĀ (PF-AES) are non-inferior to permanent-polymer zotarolimus-eluting stents (PP-ZES) in terms…

Polymer coated sustained-release Eluvia DES outshines non-polymer coated Zilver DES for femoropopliteal artery stenosis

A randomized global, prospective, multi-center, single-blind trial comparing the Eluvia paclitaxel-eluting stent…

SORT-OUT and BIONYX Successfully Demonstrate Non-Inferiority in the World of Drug-Eluting Stents

Findings from the SORT-OUT trial, presented at the 30th annual Transcatheter Cardiovascular…

Biodegradable Polymer Sirolimus- Eluting Stent Proven Non-Inferior to Durable-Polymer, Everolimus-Eluting Stent

Results of the BIOSCIENCE study that were presented at the ESC Annual…

Coronary Microvascular Dysfunction: A Promising Therapeutic Target in Heart Failure with Preserved EF?

PROMIS-HFpEF (PRevalence Of MIcrovascular dySfunction in Heart Failure with Preserved Ejection Fraction)…

Lorcaserin proven safe as weight loss agent in obese patients

The selective serotonin 2c receptor agonist, Lorcaserin has been proven to be…

Transcatheter Interatrial shunt device appears safe at 1 year for heart failure with preserved ejection fraction

The 1-year results of a phase 2, sham-controlled RCT have confirmed the…

Omega-3 fatty acid Supplements Show No Benefit in Cardiovascular Prevention in Diabetes

A randomized trial in patients with diabetes without evidence of cardiovascular disease…

Aspirin Vs Placebo In Cardiovascular Event Reduction In Diabetes

A randomized 15,480 patient strong UK based trial comparing Aspirin (ASA) versus…

Conservative Management Should be First Line Therapy for SCAD

Spontaneous coronary artery dissection (SCAD) is an underdiagnosed, poorly misunderstood condition. The…

Low Dose Rivaroxaban Plus Aspirin Reduces Major Adverse Limb Events in COMPASS

According to a new subgroup analysis of the COMPASS trial published in…